Compare Medpace Holdings Inc (MEDP) vs Star Bulk Carriers Corp (SBLK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medpace Holdings Inc vs Star Bulk Carriers Corp — how do they compare? Medpace Holdings Inc trades at $528.29 (market cap $15.08B), while Star Bulk Carriers Corp trades at $26.38 (market cap $2.91B). The key difference: Medpace Holdings Inc is far larger — about 5.2× Star Bulk Carriers Corp's market cap, and Star Bulk Carriers Corp pays a 3.95% dividend while Medpace Holdings Inc pays none. Which is the better fit depends on your goals.
| MEDP | SBLK | |
|---|---|---|
Market Cap | $15.08B | $2.91B |
Sector | Technology | Industrials |
52-Week High | $620.59 | $28.21 |
52-Week Low | $308.88 | $16.79 |
Enterprise Value | $14.55B | $3.61B |
Dividend Yield | — | 3.95% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
MEDP trades at $527.93, down 1.82% today, with a bullish technical outlook supported by moving averages. The company demonstrates strong profitability with 17.19% net margins and 77.25% ROE, though valuation ratios appear elevated with a P/E of 33.83. Recent earnings have consistently beaten expectations, and cash flow is projected to improve significantly in 2026. However, the stock faces headwinds from ongoing class action lawsuits and mixed analyst sentiment with 73.69% hold ratings.
MEDP presents a mixed investment case with strong fundamental performance offset by legal overhangs and premium valuation. The company's consistent earnings beats and projected cash flow improvement support upside potential, but investors should weigh the legal risks and cautious analyst stance against the robust operational metrics.
Star Bulk Carriers (SBLK) trades at $26.09, up 4.78% in the last session. Technical indicators are bearish, but fundamentals show strength with a P/E of 19.92 and net income margin of 13.01%. Recent earnings beat expectations in Q4 2025 and Q1 2026, with Q2 2026 EPS expected at $0.96. The company maintains a healthy balance sheet and pays dividends, including a recent $0.50 per share distribution.
Outlook is cautiously optimistic due to strong dry bulk rates and fleet modernization driving cash flow. Risks include shipping rate volatility and macroeconomic pressures. Analyst consensus is bullish with 58.34% buy ratings, but technical weakness suggests near-term caution. The stock offers value with a 10%+ dividend yield potential if rates sustain.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Medpace Holdings Inc
Medpace Holdings, Inc. is a full-service clinical contract research organization (CRO) that provides comprehensive and scientifically-driven clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company specializes in conducting global clinical trials for new drug and medical device approvals. Medpace's model emphasizes therapeutic expertise and a highly integrated approach to accelerate the clinical development process for its clients.
Read more on MEDP →About Star Bulk Carriers Corp
Star Bulk Carriers Corp. is a global shipping company specializing in the seaborne transportation of dry bulk commodities. The company owns and operates a large fleet of bulk carriers, primarily transporting major commodities such as iron ore, coal, and grain. SBLK focuses on the Capesize, Post Panamax, and Kamsarmax vessel segments, providing critical logistical services to commodity producers and consumers worldwide.
Read more on SBLK →
